2023-01-01 2023-12-31 false Capium Accounts Production 1.1 05518393 bus:FullAccounts 2023-01-01 2023-12-31 05518393 bus:FRS102 2023-01-01 2023-12-31 05518393 bus:AuditExemptWithAccountantsReport 2023-01-01 2023-12-31 05518393 bus:SmallCompaniesRegimeForAccounts 2023-01-01 2023-12-31 05518393 bus:PrivateLimitedCompanyLtd 2023-01-01 2023-12-31 05518393 2023-01-01 2023-12-31 05518393 2023-12-31 05518393 bus:RegisteredOffice 2023-01-01 2023-12-31 05518393 core:WithinOneYear 2023-12-31 05518393 core:AfterOneYear 2023-12-31 05518393 bus:Director1 2023-01-01 2023-12-31 05518393 bus:Director1 2023-12-31 05518393 bus:Director1 2022-01-01 2022-12-31 05518393 bus:Director2 2023-01-01 2023-12-31 05518393 bus:Director2 2023-12-31 05518393 bus:Director2 2022-01-01 2022-12-31 05518393 bus:Director3 2023-01-01 2023-12-31 05518393 bus:Director3 2023-12-31 05518393 bus:Director3 2022-01-01 2022-12-31 05518393 2022-01-01 05518393 bus:LeadAgentIfApplicable 2023-01-01 2023-12-31 05518393 2022-01-01 2022-12-31 05518393 2022-12-31 05518393 core:WithinOneYear 2022-12-31 05518393 core:AfterOneYear 2022-12-31 05518393 bus:EntityAccountantsOrAuditors 2022-01-01 2022-12-31 05518393 bus:OrdinaryShareClass1 2023-01-01 2023-12-31 05518393 bus:OrdinaryShareClass1 2023-12-31 05518393 bus:OrdinaryShareClass1 2022-01-01 2022-12-31 05518393 bus:OrdinaryShareClass1 2022-12-31 05518393 core:OtherResidualIntangibleAssets 2023-01-01 2023-12-31 05518393 core:OtherResidualIntangibleAssets 2023-12-31 05518393 core:OtherResidualIntangibleAssets 2022-12-31 05518393 core:CostValuation core:Non-currentFinancialInstruments 2023-12-31 05518393 core:CostValuation core:Non-currentFinancialInstruments 2022-12-31 05518393 core:AdditionsToInvestments core:Non-currentFinancialInstruments 2023-12-31 05518393 core:DisposalsDecreaseInInvestments core:Non-currentFinancialInstruments 2023-12-31 05518393 core:RevaluationsIncreaseDecreaseInInvestments core:Non-currentFinancialInstruments 2023-12-31 05518393 core:Non-currentFinancialInstruments 2023-12-31 05518393 core:Non-currentFinancialInstruments 2022-12-31 05518393 core:ShareCapital 2023-12-31 05518393 core:ShareCapital 2022-12-31 05518393 core:SharePremium 2023-12-31 05518393 core:SharePremium 2022-12-31 05518393 core:RevaluationReserve 2023-12-31 05518393 core:RevaluationReserve 2022-12-31 05518393 core:CapitalRedemptionReserve 2023-12-31 05518393 core:CapitalRedemptionReserve 2022-12-31 05518393 core:RetainedEarningsAccumulatedLosses 2023-12-31 05518393 core:RetainedEarningsAccumulatedLosses 2022-12-31 05518393 core:ShareCapitalOrdinaryShares 2023-01-01 05518393 core:ShareCapitalOrdinaryShares 2022-01-01 05518393 core:ShareCapitalOrdinaryShares 2023-01-01 2023-12-31 05518393 core:ShareCapitalOrdinaryShares 2022-01-01 2022-12-31 05518393 core:ShareCapitalOrdinaryShares 2023-12-31 05518393 core:ShareCapitalOrdinaryShares 2022-12-31 05518393 core:SharePremiumOrdinaryShares 2023-01-01 05518393 core:SharePremiumOrdinaryShares 2022-01-01 05518393 core:SharePremiumOrdinaryShares 2023-01-01 2023-12-31 05518393 core:SharePremiumOrdinaryShares 2022-01-01 2022-12-31 05518393 core:SharePremiumOrdinaryShares 2023-12-31 05518393 core:SharePremiumOrdinaryShares 2022-12-31 05518393 core:RevaluationReserve 2023-01-01 05518393 core:RevaluationReserve 2022-01-01 05518393 core:RevaluationReserve 2023-01-01 2023-12-31 05518393 core:RevaluationReserve 2022-01-01 2022-12-31 05518393 core:RevaluationReserve 2023-12-31 05518393 core:RevaluationReserve 2022-12-31 05518393 core:CapitalRedemptionReserve 2023-01-01 05518393 core:CapitalRedemptionReserve 2022-01-01 05518393 core:CapitalRedemptionReserve 2023-01-01 2023-12-31 05518393 core:CapitalRedemptionReserve 2022-01-01 2022-12-31 05518393 core:CapitalRedemptionReserve 2023-12-31 05518393 core:CapitalRedemptionReserve 2022-12-31 05518393 core:RetainedEarningsAccumulatedLosses 2023-01-01 05518393 core:RetainedEarningsAccumulatedLosses 2022-01-01 05518393 core:RetainedEarningsAccumulatedLosses 2023-01-01 2023-12-31 05518393 core:RetainedEarningsAccumulatedLosses 2022-01-01 2022-12-31 05518393 core:RetainedEarningsAccumulatedLosses 2023-12-31 05518393 core:RetainedEarningsAccumulatedLosses 2022-12-31 05518393 dpl:Item1 2023-01-01 05518393 dpl:Item1 2023-12-31 05518393 dpl:Item1 2022-01-01 05518393 dpl:Item1 2022-12-31 iso4217:GBP xbrli:shares xbrli:pure
Registered Number: 05518393
England and Wales

 

 

 

ALIGN-ALYTICS HOLDINGS LTD


Unaudited Financial Statements
 


Period of accounts

Start date: 01 January 2023

End date: 31 December 2023
Directors Patrick Charles Mosimann
Steven Mark Whant
Roland Mosimann
Registered Number 05518393
Registered Office LABS, HOGARTH HOUSE
HIGH HOLBORN
LONDON
WC1V 6PX
Accountants Pace Accountancy Ltd
3 The Retreat, Glebe Lane
Abberton
Colchester
CO5 7NW
1
 
 
Notes
 
2023
£
  2022
£
Fixed assets      
Investments 4 8,133,587    8,133,587 
8,133,587    8,133,587 
Current assets      
Debtors 5 43,195    30,229 
Cash at bank and in hand 223    1,815 
43,418    32,044 
Creditors: amount falling due within one year 6 (1,250,288)   (1,182,664)
Net current assets (1,206,870)   (1,150,620)
 
Total assets less current liabilities 6,926,717    6,982,967 
Creditors: amount falling due after more than one year 7 (298,617)   (287,617)
Net assets 6,628,100    6,695,350 
 

Capital and reserves
     
Called up share capital 8 70    71 
Share premium account 9 24    24 
Reserves 10 7,295,998    7,295,998 
Capital Redemption Reserve 11 27    26 
Profit and loss account (668,019)   (600,769)
Shareholders' funds 6,628,100    6,695,350 
 


For the year ended 31 December 2023 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

Directors' responsibilities:
  1. The members have not required the company to obtain an audit of its accounts for the year in question in accordance with section 476.
  2. The directors acknowledge their responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of accounts.
These financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime. In accordance with Section 444 of the Companies Act 2006, the income statement has not been delivered to the Registrar of Companies.
The financial statements were approved by the board of directors on 20 September 2024 and were signed on its behalf by:


-------------------------------
Steven Mark Whant
Director
2
  Equity share capital   Equity share premium   Revaluation reserve   Capital redemption reserve   Retained Earnings   Total
£ £ £ £ £ £
At 01 January 2022 76  24  5,832,812  21  (465,096) 5,367,837 
Profit for the year (135,673) (135,673)
Revaluation of Fixed Assets 1,463,186  1,463,186 
Purchase of own shares (nominal value)
Total comprehensive income for the year 1,463,186  5  (135,673) 1,327,518 
Shares redeemed (5) (5)
Total investments by and distributions to owners (5) (5)
At 31 December 2022 71  24  7,295,998  26  (600,769) 6,695,350 
At 01 January 2023 70  24  7,295,998  27  (600,769) 6,695,350 
Profit for the year (67,250) (67,250)
Total comprehensive income for the year (67,250) (67,250)
Total investments by and distributions to owners
At 31 December 2023 70  24  7,295,998  27  (668,019) 6,628,100 
3
General Information
ALIGN-ALYTICS HOLDINGS LTD is a private company, limited by shares, registered in England and Wales, registration number 05518393, registration address LABS, HOGARTH HOUSE, HIGH HOLBORN , LONDON, WC1V 6PX.

The presentation currency is £ sterling.


On 10 October 2022 the company's registered name was changed by a resolution dated 5 October 2022 from PMSI UK Ltd to Align-Alytics Holdings Ltd
1.

Accounting policies

Significant accounting policies
The accounts have been prepared under the historical cost convention and in accordance with FRS 102, the Financial Reporting Standard applicable in the UK and Republic of Ireland (as applied to small entities by Section 1A of the standard)
Group accounts
The company is a parent company subject to the small companies regime. The company and its subsidiary comprise a small group. The company has, therefore, taken advantage of the option provided by section 398 of the Companies Act 2006 not to prepare group accounts.
Going concern basis
The directors  have a reasonable expectation that the company has adequate resources to continue in operational existence for the foreseeable future. Thus they continue to adopt the going concern basis of accounting in preparing the financial statements.
Turnover
Turnover comprises the invoiced value of goods and services supplied by the company, net of Value Added Tax and trade discounts.
Research and development expenditure
Research and development expenditure is charged to the income statement in the period in which it is incurred.
Foreign currencies
Monetary assets and liabilities denominated in foreign currencies are translated into sterling at the rate of exchange ruling at the statement of financial position date. Transactions in foreign currencies are recorded at the rate ruling at the date of the transaction. All foreign exchange differences are included to the income statement.
Taxation
Taxation represents the sum of tax currently payable and deferred tax. Tax is recognised in the statement of income, except to the extent that it relates to items recognised in other comprehensive income or directly in capital and reserves.
The company’s liability for current tax is calculated using the tax rates and laws that have been enacted or substantively enacted at the reporting date.
Current and deferred tax assets and liabilities are not discounted
Deferred taxation
Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the reporting date.
Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the reporting date that are expected to apply to the reversal of the timing difference.
Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.
Current and deferred tax assets and liabilities are not discounted.
Intangible assets
Intangible assets (including purchased goodwill and patents) are amortised at rates calculated to write off the assets on a straight line basis over their estimated useful economic lives. Impairment of intangible assets is only reviewed where circumstances indicate that the carrying value of an asset may not be fully recoverable.
Licences and patents
Licences and patents are stated at cost less amortisation. Amortisation of licences is calculated on a straight line basis over the life of the licence. Amortisation of patents is calculated on a straight line basis over the estimated expected useful economic life of the patents of 5 years.
Fixed asset investments
Fixed asset investments are stated at cost less provision for any permanent diminution in value.
2.

Average number of employees

Average number of employees during the year was 2 (2022 : 2).
3.

Intangible fixed assets

Cost Other   Total
  £   £
At 01 January 2023 2,439,024    2,439,024 
Additions  
Disposals  
At 31 December 2023 2,439,024    2,439,024 
Amortisation
At 01 January 2023 2,439,024    2,439,024 
Charge for year  
On disposals  
At 31 December 2023 2,439,024    2,439,024 
Net book values
At 31 December 2023  
At 31 December 2022  

Intangible assets carried at revalued amounts
The fair value of the company's Patents was revalued on 1 October 2016. An independent valuer was not involved. 
The directors revalued the Intellectual Property rights at £2,439,024 on the basis of estimated future earnings attributable. These have now been written off in full over a period of five years since acquisition in December 2014..
Had this class of asset been measured on a historical cost basis, their carrying amount would have been  £1,914,715 (2021 - £1,914,715).

4.

Investments

Cost Investments in participating interests   Total
  £   £
At 01 January 2023 837,589    837,589 
Additions  
Transfer to/from tangible fixed assets  
Disposals  
Revaluations 7,295,998    7,295,998 
At 31 December 2023 8,133,587    8,133,587 
Details of undertakings
Details of the investments (including principal place of business of unincorporated entities) in which the company holds 20% or more of the nominal value of any class of share capital are as follows:

Subsidiary undertakings
Undertaking                Registered Office                       Holding        Votes & shares held
                                                                                                                        2023         2022   
Business Intelligence     1055 Westlakes Drive, Suite    Common            100%        100%
International, Inc.            300, Berwyn, PA19312, USA    stock

The principal activity of Business Intelligence International, Inc. is Management consultancy and software.
Undertaking                 Registered Office                      Holding          Votes & shares held
                                                                                                                             2023        2022 
Align-Alytics UK Ltd        LABS, Hogarth House            Ordinary                100%       100%
                                            High Holborn, London            shares
                                            WC1V 6PX, England

The principal activity of Align-Alytics UK Ltd is Management consultancy.

Participating interest  
Undertaking                   Registered Office                 Holding               Votes  held
                                                                                                                              2023       2022 
Correlaction BV                De Els 14, RK Dongen            Ordinary                35.51%    35.51%
                                            Netherlands                            A, B & C 

The A shares are non-voting shares. The overall share of equity at the year end was 45.98% (2022: 45.98%)

The principal activity of Correlaction BV is financial management software and consultancy.                     


5.

Debtors: amounts falling due within one year

2023
£
  2022
£
Trade Debtors  
Other Debtors 43,195    30,179 
VAT   50 
43,195    30,229 

6.

Creditors: amount falling due within one year

2023
£
  2022
£
Trade Creditors 7,880    7,880 
Amounts Owed to Group Undertakings 1,080,488    1,161,561 
Amounts Owed to Participating Interests 6,882    13,211 
Other Creditors (2)   (1)
Directors' Current Accounts   13 
VAT 155,040   
1,250,288    1,182,664 

7.

Creditors: amount falling due after more than one year

2023
£
  2022
£
Other Creditors 298,617    287,617 
298,617    287,617 

8.

Share Capital

Allotted, called up and fully paid
2023
£
  2022
£
7,557,259 Class A shares of £0.00001 each 76    76 
76    76 

9.

Share premium account

2023
£
  2022
£
Equity Share Premium b/fwd 24    24 
24    24 

10.

Reserves

2023
£
  2022
£
Revaluation Reserve b/fwd 7,295,998    5,832,812 
Revaluation of Fixed Assets   1,463,186 
7,295,998    7,295,998 

11.

Capital Redemption Reserve

2023
£
  2022
£
Capital Redemption Reserve b/fwd 27    21 
Purchase of Own Shares (Nominal Value)  
27    26 

12.

Related parties

During the year the company entered into the following transactions with related parties:
Transaction value - income/(expenses) Balance owed by/(owed to)
2023
£
 2022
£
 2023
£
 2022
£
Align-Alytics UK Limited(775,449)(155,384)(293,084)
Business Intelligence Inc(94,557)(94,557)(928,104)(868,478)
Correlaction BV5,202 781,619 (7,933)(13,211)
4